Leonard Liebes

7.7k total citations · 1 hit paper
129 papers, 6.2k citations indexed

About

Leonard Liebes is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Leonard Liebes has authored 129 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 52 papers in Oncology and 16 papers in Genetics. Recurrent topics in Leonard Liebes's work include Cancer therapeutics and mechanisms (15 papers), Cancer Treatment and Pharmacology (13 papers) and Ovarian cancer diagnosis and treatment (12 papers). Leonard Liebes is often cited by papers focused on Cancer therapeutics and mechanisms (15 papers), Cancer Treatment and Pharmacology (13 papers) and Ovarian cancer diagnosis and treatment (12 papers). Leonard Liebes collaborates with scholars based in United States, Australia and Israel. Leonard Liebes's co-authors include Bruce Ng, James S. Babb, Silvia C. Formenti, Sandra Demaria, Noriko Kawashima, M. Devitt, Franco M. Muggia, Román Pérez-Soler, Yi‐He Ling and Yiyu Zou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Leonard Liebes

129 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

2004 1.1k citations Sandra Demaria, Bruce Ng et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers

Countries citing papers authored by Leonard Liebes

Since Specialization

Citations

This map shows the geographic impact of Leonard Liebes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonard Liebes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonard Liebes more than expected).

Fields of papers citing papers by Leonard Liebes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonard Liebes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonard Liebes. The network helps show where Leonard Liebes may publish in the future.

Co-authorship network of co-authors of Leonard Liebes

This figure shows the co-authorship network connecting the top 25 collaborators of Leonard Liebes. A scholar is included among the top collaborators of Leonard Liebes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonard Liebes. Leonard Liebes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted amplification of delivery to cell surface receptors by dendrimer self-assembly 2014 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Michael Buckley, Xiaojian Wang, (unknown), Leonard Liebes, James W. Canary	2
2	Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer 2012 ·Clinical Cancer Research ·Sylvia Adams, Lina Kozhaya, Frank Martiniuk, Tze‐Chiang Meng, Luis Chiriboga, Leonard Liebes, Tsivia Hochman, (unknown), Deborah Axelrod, James L. Speyer, Yelena Novik, Amy Tiersten, Judith D. Goldberg, Silvia C. Formenti, Nina Bhardwaj, Derya Unutmaz, Sandra Demaria	184
3	The Numbers of FoxP3+ Lymphocytes in Sentinel Lymph Nodes of Breast Cancer Patients Correlate With Primary Tumor Size but Not Nodal Status 2011 ·Cancer Investigation ·Raavi Gupta, James S. Babb, Baljit Singh, Luis Chiriboga, Leonard Liebes, Sylvia Adams, Sandra Demaria	12
4	Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer 2010 ·Cancer Chemotherapy and Pharmacology ·Eleni Andreopoulou, Tai C. Chen, Leonard Liebes, John P. Curtin, Stephanie V. Blank, Robert C. Wallach, Howard S. Höchster, Franco M. Muggia	9
5	The possible role of the kynurenine pathway in adolescent depression with melancholic features 2010 ·Journal of Child Psychology and Psychiatry ·Vilma Gabbay, Rachel G. Klein, Yisrael Katz, Sandra Mendoza, (unknown), Carmen Alonso, James S. Babb, Glenn S. Hirsch, Leonard Liebes	100
6	Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment 2010 ·Gynecologic Oncology ·Stephanie V. Blank, Paul J. Christos, John P. Curtin, Noah A. Goldman, Carolyn D. Runowicz, Joseph A. Sparano, Leonard Liebes, Helen X. Chen, Franco M. Muggia	40
7	The kynurenine pathway in adolescent depression: Preliminary findings from a proton MR spectroscopy study 2009 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Vilma Gabbay, Leonard Liebes, Yisrael Katz, Songtao Liu, Sandra Mendoza, James S. Babb, Rachel G. Klein, Oded Gonen	52
8	Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients 2008 ·Journal of Translational Medicine ·Jessie Z. Yu, Melanie Warycha, Paul J. Christos, Farbod Darvishian, Herman Yee, (unknown), Russell S. Berman, Richard L. Shapiro, Michael Buckley, Leonard Liebes, Anna C. Pavlick, David Polsky, Peter C. Brooks, Iman Osman	9
9	The vitamin-like dietary supplement para-aminobenzoic acid enhances the antitumor activity of ionizing radiation 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Sandhya Xavier, (unknown), Jennifer Roth, Maresa Caunt, Abebe Akalu, (unknown), Michael Buckley, Leonard Liebes, Silvia C. Formenti, Peter C. Brooks	18
10	Para-aminobenzoic acid (PABA) enhances the in-vitro tumor response of ovarian cancer to Topotecan (TTN) through mitochondrial-mediated apoptosis 2005 ·Cancer Research ·Michael Buckley, David Newman, Leonard Liebes, Elissa L. Kramer, Bruce Ng, James S. Babb, Peter C. Brooks, John P. Curtin	3
11	Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated breakdown → 2004 ·International Journal of Radiation OncologyBiologyPhysics ·Sandra Demaria, Bruce Ng, M. Devitt, James S. Babb, Noriko Kawashima, Leonard Liebes, Silvia C. Formenti	1061
12	Phase I and pharmacologic study of i.p. 9-aminocamptothecin given as six fractions over 14 days 2002 ·Anti-Cancer Drugs ·Franco M. Muggia, Leonard Liebes, Maitreyee Hazarika, Scott Wadler, Anne Hamilton, Gila Hornreich, Joan Sorich, (unknown), Elliot Newman, M Potmĕsil, Howard S. Höchster	9
13	Initial clinical evaluation of radiolabeled MX-DTPA humanized BrE-3 antibody in patients with advanced breast cancer. 1998 ·PubMed ·E. Kramer, Leonard Liebes, Carolyn Wasserheit, Marilyn E. Noz, Edward W. Blank, (unknown), Jonathan Melamed, Philip Furmanski, Jerry A. Peterson, R. L. Ceriani	29
14	Biologic Activity of Interleukin 1 (IL-1) Alpha in Patients with Refractory Malignancies 1998 ·Journal of Immunotherapy ·Mark Rosenthal, David T. Dennis, Leonard Liebes, (unknown), Dania Caron, Leslie Garrison, (unknown), (unknown), Ruth Oratz, James L. Speyer, Abraham Chachoua	4
15	Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study. 1997 ·PubMed ·Howard S. Höchster, Leonard Liebes, James L. Speyer, Joan Sorich, (unknown), Ruth Oratz, J Wernz, Abraham Chachoua, Ronald H. Blum, Anne Zeleniuch‐Jacquotte	49
16	Pharmacodynamics/pharmacokinetics of intragastric camptothecin analogs in a human-cancer xenograft model 1995 ·M Potmĕsil, Leonard Liebes, (unknown), S Sekiya, Lawrence S. Morse, Anthony J. Kozielski, Monroe E. Wall, Mansukh C. Wani, John S. Stehlin, Beppino C. Giovanella	4
17	Hypericin as an inactivator of infectious viruses in blood components 1995 ·Transfusion ·G. Lavie, Y. MAZUR, David Lavie, A. M. Prince, Donna Pascual, Leonard Liebes, Brandi Levin, Daniel Meruelo	88
18	Good tolerance of weekly oral idarubicin: (4-demethoxydaunorubicin): A phase I study with pharmacology 1990 ·Cancer Chemotherapy and Pharmacology ·Howard S. Höchster, Michael Green, Leonard Liebes, James L. Speyer, James C. Wernz, Ronald H. Blum, Franco M. Muggia	9
19	Transfer of Zidovudine (AZT) by Human Placenta 1990 ·The Journal of Infectious Diseases ·Leonard Liebes, Sandra Mendoza, Donna Wilson, Joseph Dancis	70
20	Toxicity of Combined Ganciclovir and Zidovudine for Cytomegalovirus Disease Associated with AIDS 1990 ·Annals of Internal Medicine ·Howard S. Höchster, Douglas T. Dieterich, Samuel A. Bozzette, Richard C. Reichman, James D. Connor, Leonard Liebes, (unknown), Stephen A. Spector, Fred Valentine, Carla Pettinelli, (unknown)	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact